Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Identification of early environmental risk factors for irritable bowel syndrome and dyspepsia.

Koloski NA, Jones M, Weltman M, Kalantar J, Bone C, Gowryshankar A, Walker MM, Talley NJ.

Neurogastroenterol Motil. 2015 Sep;27(9):1317-25. doi: 10.1111/nmo.12626. Epub 2015 Jul 22.

PMID:
26202154
2.

α-Methyldopa-induced hepatitis during the postpartum period.

Kashkooli S, Baraty B, Kalantar J.

BMJ Case Rep. 2014 Feb 27;2014. pii: bcr2014203712. doi: 10.1136/bcr-2014-203712.

3.

Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an Australian cohort.

Walker MM, Aggarwal KR, Shim LS, Bassan M, Kalantar JS, Weltman MD, Jones M, Powell N, Talley NJ.

J Gastroenterol Hepatol. 2014 Mar;29(3):474-9. doi: 10.1111/jgh.12419.

PMID:
24304041
4.

Psychological impact and risk factors associated with new onset fecal incontinence.

Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ.

J Psychosom Res. 2012 Dec;73(6):464-8. doi: 10.1016/j.jpsychores.2012.07.013. Epub 2012 Aug 19.

PMID:
23148816
5.

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study.

Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ.

Gut. 2012 Sep;61(9):1284-90. doi: 10.1136/gutjnl-2011-300474. Epub 2012 Jan 10.

PMID:
22234979
6.

The impact of laxative use upon symptoms in patients with proven slow transit constipation.

Dinning PG, Hunt L, Lubowski DZ, Kalantar JS, Cook IJ, Jones MP.

BMC Gastroenterol. 2011 Nov 10;11:121. doi: 10.1186/1471-230X-11-121.

7.

Gastrointestinal Mantle Cell Lymphoma-A Tale of Two Endoscopies.

Dantoc MM, Eslick GD, Adams SS, Kalantar JS.

J Gastrointest Cancer. 2012 Sep;43 Suppl 1:S20-4. doi: 10.1007/s12029-011-9282-0.

PMID:
21556723
8.

Working overseas, weakness, anaemia, and nematodes.

Eslick GD, Kalantar JS.

Travel Med Infect Dis. 2011 Mar;9(2):91-2. doi: 10.1016/j.tmaid.2011.02.006. Epub 2011 Mar 12.

PMID:
21402496
9.

Gastric metastasis in renal cell carcinoma: a case report and systematic review.

Eslick GD, Kalantar JS.

J Gastrointest Cancer. 2011 Dec;42(4):296-301. doi: 10.1007/s12029-010-9165-9. Review.

PMID:
20514555
10.

Rectal bleeding: epidemiology, associated risk factors, and health care seeking behaviour: a population-based study.

Eslick GD, Kalantar JS, Talley NJ.

Colorectal Dis. 2009 Nov;11(9):921-6. doi: 10.1111/j.1463-1318.2008.01721.x. Epub 2008 Oct 21.

PMID:
19175652
11.

A case of chronic intestinal pseudo-obstruction secondary to primary visceral myopathy.

Shim LS, Eslick GD, Kan AE, Kalantar JS.

Nat Clin Pract Gastroenterol Hepatol. 2008 Oct;5(10):584-8. doi: 10.1038/ncpgasthep1254. Epub 2008 Sep 9.

PMID:
18779848
12.

Gastrointestinal: eosinophilic colitis.

Shim LS, Eslick GD, Kalantar JS.

J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1305. doi: 10.1111/j.1440-1746.2008.05522.x. No abstract available.

PMID:
18699981
13.

Education and imaging. Gastrointestinal: laryngopharyngeal cancers detected at upper gastrointestinal endoscopy.

Eslick GD, Kalantar JS, Roberts-Thomson IC.

J Gastroenterol Hepatol. 2007 Mar;22(3):447. No abstract available.

PMID:
17295783
14.

Granulation and fibrotic esophagus.

Eslick GD, Sethi S, Kalantar JS.

Scand J Gastroenterol. 2006 Jun;41(6):761-2.

PMID:
16716980
15.

Familial aggregation of irritable bowel syndrome: a prospective study.

Kalantar JS, Locke GR 3rd, Zinsmeister AR, Beighley CM, Talley NJ.

Gut. 2003 Dec;52(12):1703-7.

16.

Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points.

Kalantar JS, Locke GR 3rd, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd.

Aliment Pharmacol Ther. 2003 Jun 1;17(11):1389-97.

17.
18.

ABC of the upper gastrointestingal tract: Indigestion: When is it functional?

Talley NJ, Phung N, Kalantar JS.

BMJ. 2001 Dec 1;323(7324):1294-7. Review. No abstract available.

19.

Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease.

Xia HH, Phung N, Kalantar JS, Talley NJ.

Med J Aust. 2000 Nov 20;173(10):515-9.

PMID:
11194733
20.

Can helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia?

Xia HH, Kalantar JS, Mitchell HM, Talley NJ.

Aliment Pharmacol Ther. 2000 May;14(5):615-24.

21.

High sensitivity and specificity of a laboratory-based serological test, pylori DTect ELISA, for detection of Helicobacter pylori infection.

Xia HH, Kalantar JS, Wyatt JM, Adams S, Cheung K, Eslick GD, Talley NJ.

Diagn Microbiol Infect Dis. 2000 Feb;36(2):69-74.

PMID:
10705045
22.

Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?

Xia HH, Kalantar JS, Talley NJ, Wyatt JM, Adams S, Chueng K, Mitchell HM.

Am J Gastroenterol. 2000 Jan;95(1):114-21.

PMID:
10638568
23.
24.

Disease-specific outcomes assessment for irritable bowel syndrome.

Kalantar JS, Locke GR 3rd.

Gastrointest Endosc Clin N Am. 1999 Oct;9(4):685-95, viii-ix. Review.

PMID:
10495233
25.

Chronic gastritis and nonulcer dyspepsia.

Kalantar J, Eslick GD, Talley NJ.

Curr Top Microbiol Immunol. 1999;241:31-45. Review. No abstract available.

PMID:
10087655

Supplemental Content

Loading ...
Support Center